NUVISAN Innovation Campus Berlin (ICB) is a dynamic contract research institute, founded by the acquisition of a complete pharma R&D unit. With all necessary capabilities and capacities available under one roof in Berlin, and with decades of pharma expertise in a broad range of disease indications, NUVISAN ICB provides fully integrated drug discovery and early development services to its pharma/biotech and startup/VC clients.